期刊文献+

美洛昔康和炎痛喜康的合成 被引量:4

Synthesis of Meloxicam and Piroxicam
暂未订购
导出
摘要 以氯乙酸异丙酯和糖精钠为原料 ,经过 4-羟基 - 2 -甲基 - 2 H - 1 ,2 -苯并噻嗪 - 3 -羧酸异丙酯1 ,1 -二氧化物中间体对美洛昔康和炎痛喜康进行合成研究。总收率分别为 5 3 .9%和 5 1 .9% Synthesis of meloxicam and piroxicam from isopropyl chloroacetate and saccharin sodium dihydrate, through the intermediate of isopropyl 4 hydroxy 2 methyl 2 H 1,2 benzothiazine 3 carboxylate 1,1 dioxide was realized. The total yield is 53.9% and 51.9%, respectively.
出处 《华东理工大学学报(自然科学版)》 CAS CSCD 北大核心 2002年第3期282-284,共3页 Journal of East China University of Science and Technology
关键词 美洛昔康 炎痛喜康 合成 非甾体消炎药 NSAIDs meloxicam piroxicam synthesis
  • 相关文献

参考文献4

二级参考文献1

  • 1叶金朝,国外医药.合成药、生化药、制剂分册,1997年,18卷,5期,273页

共引文献16

同被引文献35

  • 1陶凯雄,张宁,王国斌,吴相柏.美洛昔康对结肠癌细胞VEGF和angiopoietin-2表达的影响[J].世界华人消化杂志,2006,14(13):1277-1282. 被引量:7
  • 2[3]Kadin S B.Antiulcer 2-thiazolyloxalam ic acids,esters and amides[P].US:4321372,1982-03-23.(CA1982,97:55796x)
  • 3[4]Trummlitz G,Engel W.4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide1,1-dioxides[P].DE:2756113,1979-06-21.(CA1979,91:91656m)
  • 4[5]Lazer E S,MiaoC K,Cywin C L,et al.Effect of structural modification of enol-carboxamide type nonsteroidal antiinflam-matory drugs on COX-2 /COX-1 selectivity[J].J Med Chem,1997,40(6):980-989.
  • 5[7]Erenmeyer H,Herzfeld L,Prijs B.Helv Chim Acta,1955;38:1291.(CA1956;50:12984h)
  • 6[13]Kulkarni K D,Shirsat M V.Chemistry of the thiazole synthesis of 2-amino-5-alkylthiazole[J].J Sci and Ind.Research,1959,1813,411-413.(CA1960;5414230f)
  • 7Elisabete W,Jerome A, Freddie IB, et al. Trends in corpusuteri cancer mortality in member states of the European Union[J]. EurJ Cancer,2014 ,50(9) :1675-1675.
  • 8Curigliano G. New drugs for breast cancer subtypes: targeting driver pathways to overcome resistance[J]. Cancer Treat Rev,2012,38(4) ,303-303.
  • 9Hoelder S, Clarke PA, Workman, P. Discovery of small molecule cancer drugs: successes, challenges and opportunities] L]. Mol Oncol,2012,6(2) ,155-155.
  • 10Ready A, Velicer eM , McTiernan A, et al. NSAID use and breast cancer risk in the VITAL cohort[J] . Breast Cancer Res Treat,2008,109(3) :533-543.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部